These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 34230999)

  • 1. Hypercalcemia in non-Hodgkin's lymphoma due to cosecretion of PTHrP and 1,25-dihydroxyvitamin D.
    Gonciulea AR; Wang Y; Bikle DD; Sellmeyer DE
    Osteoporos Int; 2021 Dec; 32(12):2587-2592. PubMed ID: 34230999
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Parathyroid-hormone-related peptide in hematologic malignancies.
    Kremer R; Shustik C; Tabak T; Papavasiliou V; Goltzman D
    Am J Med; 1996 Apr; 100(4):406-11. PubMed ID: 8610726
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 1,25-dihydroxyvitamin D and PTHrP mediated malignant hypercalcemia in a seminoma.
    Rodríguez-Gutiérrez R; Zapata-Rivera MA; Quintanilla-Flores DL; Camara-Lemarroy CR; Lavalle-Gonzalez FJ; González-González JG; Villarreal-Pérez JZ
    BMC Endocr Disord; 2014 Apr; 14():32. PubMed ID: 24721620
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Parathyroid hormone (PTH)-related protein, PTH, and 1,25-dihydroxyvitamin D in dogs with cancer-associated hypercalcemia.
    Rosol TJ; Nagode LA; Couto CG; Hammer AS; Chew DJ; Peterson JL; Ayl RD; Steinmeyer CL; Capen CC
    Endocrinology; 1992 Sep; 131(3):1157-64. PubMed ID: 1505457
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Parathyroid hormone-related protein (PTHrP) does not regulate 1,25-dihydroxyvitamin D serum levels in hypercalcemia of malignancy.
    Schilling T; Pecherstorfer M; Blind E; Leidig G; Ziegler R; Raue F
    J Clin Endocrinol Metab; 1993 Mar; 76(3):801-3. PubMed ID: 8445039
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Direct comparison of sustained infusion of human parathyroid hormone-related protein-(1-36) [hPTHrP-(1-36)] versus hPTH-(1-34) on serum calcium, plasma 1,25-dihydroxyvitamin D concentrations, and fractional calcium excretion in healthy human volunteers.
    Horwitz MJ; Tedesco MB; Sereika SM; Hollis BW; Garcia-Ocaña A; Stewart AF
    J Clin Endocrinol Metab; 2003 Apr; 88(4):1603-9. PubMed ID: 12679445
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hypercalcemia of Malignancy: Simultaneous Elevation in Parathyroid Hormone-Related Peptide and 1,25 Dihydroxyvitamin D in Sarcoma.
    Kim DW; Miller A; Li A; Hardy N; Silver KD
    AACE Clin Case Rep; 2021; 7(3):169-173. PubMed ID: 34095480
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Malignancy-associated hypercalcaemia: resolution of controversies over vitamin D metabolism by a pathophysiological approach to the syndrome.
    Schweitzer DH; Hamdy NA; Frölich M; Zwinderman AH; Papapoulos SE
    Clin Endocrinol (Oxf); 1994 Aug; 41(2):251-6. PubMed ID: 7923831
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Malignant Hypercalcemia Due to the Ectopic Production of Calcitriol by an Abdominal Liposarcoma.
    Figueiredo A; Pereira T; Cabrera R; Simões-Pereira J; Leite V
    Cureus; 2023 Jan; 15(1):e33446. PubMed ID: 36751194
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of treatment of malignancy-associated hypercalcemia on serum parathyroid hormone-related protein.
    Budayr AA; Zysset E; Jenzer A; Thiébaud D; Ammann P; Rizzoli R; Jaquet-Müller F; Bonjour JP; Gertz B; Burckhardt P
    J Bone Miner Res; 1994 Apr; 9(4):521-6. PubMed ID: 8030440
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hypercalcemia associated with infection by Cryptococcus neoformans and Coccidioides immitis.
    Ali MY; Gopal KV; Llerena LA; Taylor HC
    Am J Med Sci; 1999 Dec; 318(6):419-23. PubMed ID: 10616168
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 1,25 dihydroxyvitamin D and dexamethasone decrease in vivo Walker carcinoma growth, but not parathyroid hormone related protein secretion.
    Cohen-Solal ME; Bouizar Z; Denne MA; Graulet AM; Gueris J; Bracq S; Jullienne A; de Vernejoul MC
    Horm Metab Res; 1995 Sep; 27(9):403-7. PubMed ID: 8557238
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Conflicting actions of parathyroid hormone-related protein and serum calcium as regulators of 25-hydroxyvitamin D(3)-1 alpha-hydroxylase expression in a nude rat model of humoral hypercalcemia of malignancy.
    Michigami T; Yamato H; Suzuki H; Nagai-Itagaki Y; Sato K; Ozono K
    J Endocrinol; 2001 Nov; 171(2):249-57. PubMed ID: 11691644
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of parathyroid hormone on renal calbindin-D28k.
    Hemmingsen C; Staun M; Lewin E; Nielsen PK; Olgaard K
    J Bone Miner Res; 1996 Aug; 11(8):1086-93. PubMed ID: 8854244
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hypercalcemia and Renal Mass: A Diagnostically Challenging Case.
    Karki S; Galiveeti S; Leung V
    Cureus; 2021 Jul; 13(7):e16718. PubMed ID: 34513354
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Parathyroid hormone-related protein, parathyroid hormone, and vitamin D in hypercalcemia of malignancy.
    Motellón JL; Javort Jiménez F; de Miguel F; Jaras MJ; Díaz A; Hurtado J; Esbrit P
    Clin Chim Acta; 2000 Jan; 290(2):189-97. PubMed ID: 10660809
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hypercalcemia of Malignancy Attributed to Cosecretion of PTH and PTHRP in Lung Adenocarcinoma.
    Kroopnick JM; Martinez-Outschoorn U; Tuluc M; Kim CS
    AACE Clin Case Rep; 2021; 7(3):200-203. PubMed ID: 34095488
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hypercalcemia of malignancy in metastatic esophageal squamous cell carcinoma with simultaneous PTHrP and calcitriol overproduction: A case report with literature review.
    Song R; Bijay Y; Rizk SH; Cao S
    Ann Med Surg (Lond); 2021 Aug; 68():102667. PubMed ID: 34401137
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Continuous PTH and PTHrP infusion causes suppression of bone formation and discordant effects on 1,25(OH)2 vitamin D.
    Horwitz MJ; Tedesco MB; Sereika SM; Syed MA; Garcia-Ocaña A; Bisello A; Hollis BW; Rosen CJ; Wysolmerski JJ; Dann P; Gundberg C; Stewart AF
    J Bone Miner Res; 2005 Oct; 20(10):1792-803. PubMed ID: 16160737
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum 1,25-dihydroxyvitamin D may be related inversely to disease activity in breast cancer patients with bone metastases.
    Mawer EB; Walls J; Howell A; Davies M; Ratcliffe WA; Bundred NJ
    J Clin Endocrinol Metab; 1997 Jan; 82(1):118-22. PubMed ID: 8989244
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.